Sen-Jam Pharma launches Phase II trial of hangover prevention treatment
A previous pilot study examining the company’s SJP-001 compound found it was able to cut hangover symptoms such as headaches, nausea, and dizziness.
20 November 2024
20 November 2024
A previous pilot study examining the company’s SJP-001 compound found it was able to cut hangover symptoms such as headaches, nausea, and dizziness.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.